These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33642532)

  • 1. [Mechanism of axonal degeneration: from molecular signaling to the development of therapeutic applications].
    Araki T
    Nihon Yakurigaku Zasshi; 2021; 156(2):66-70. PubMed ID: 33642532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system.
    Coleman MP; Ribchester RR
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):227-38. PubMed ID: 15180483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms in the initiation phase of Wallerian degeneration.
    Chang B; Quan Q; Lu S; Wang Y; Peng J
    Eur J Neurosci; 2016 Aug; 44(4):2040-8. PubMed ID: 27062141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelination can proceed independently of axonal degradation during Wallerian degeneration in wlds mice.
    Takada H; Yuasa S; Araki T
    Eur J Neurosci; 2011 Aug; 34(4):531-7. PubMed ID: 21749497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of axons that struggle to make ends meet: Linking axonal bioenergetic failure to programmed axon degeneration.
    Babetto E; Beirowski B
    Biochim Biophys Acta Bioenerg; 2022 Jun; 1863(5):148545. PubMed ID: 35339437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration.
    Beirowski B; Nógrádi A; Babetto E; Garcia-Alias G; Coleman MP
    J Neuropathol Exp Neurol; 2010 May; 69(5):455-72. PubMed ID: 20418780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal Degeneration in Retinal Ganglion Cells Is Associated with a Membrane Polarity-Sensitive Redox Process.
    Almasieh M; Catrinescu MM; Binan L; Costantino S; Levin LA
    J Neurosci; 2017 Apr; 37(14):3824-3839. PubMed ID: 28275163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescuing axons from degeneration does not affect retinal ganglion cell death.
    de Lima S; Mietto BS; Paula C; Muniz T; Martinez AM; Gardino PF
    Braz J Med Biol Res; 2016; 49(4):e5106. PubMed ID: 27007653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration.
    Krauss R; Bosanac T; Devraj R; Engber T; Hughes RO
    Trends Pharmacol Sci; 2020 Apr; 41(4):281-293. PubMed ID: 32107050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2.
    Yamagishi Y; Tessier-Lavigne M
    Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traumatic axonal injury in the perisomatic domain triggers ultrarapid secondary axotomy and Wallerian degeneration.
    Kelley BJ; Farkas O; Lifshitz J; Povlishock JT
    Exp Neurol; 2006 Apr; 198(2):350-60. PubMed ID: 16448652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord.
    Sayer FT; Oudega M; Hagg T
    Exp Neurol; 2002 May; 175(1):282-96. PubMed ID: 12009779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of neuronal/axonal degeneration by ZNRF1 ubiquitin ligase.
    Araki T; Wakatsuki S
    Neurosci Res; 2019 Feb; 139():21-25. PubMed ID: 30118738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol delays Wallerian degeneration in a NAD(+) and DBC1 dependent manner.
    Calliari A; Bobba N; Escande C; Chini EN
    Exp Neurol; 2014 Jan; 251():91-100. PubMed ID: 24252177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Imaging of Secondary Neurodegeneration Associated With Phosphatidylserine Externalization Along Axotomized Axons.
    Yang F; Almasieh M; Levin LA
    Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):24. PubMed ID: 38345553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conditioning lesion protects axons from degeneration via the Wallenda/DLK MAP kinase signaling cascade.
    Xiong X; Collins CA
    J Neurosci; 2012 Jan; 32(2):610-5. PubMed ID: 22238096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal Degeneration Is Mediated by Necroptosis Activation.
    Arrázola MS; Saquel C; Catalán RJ; Barrientos SA; Hernandez DE; Martínez NW; Catenaccio A; Court FA
    J Neurosci; 2019 May; 39(20):3832-3844. PubMed ID: 30850513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury.
    Chen P; Piao X; Bonaldo P
    Acta Neuropathol; 2015 Nov; 130(5):605-18. PubMed ID: 26419777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A affects axons and macrophages during Wallerian degeneration.
    Taskinen HS; Röyttä M
    J Neurotrauma; 2000 May; 17(5):431-40. PubMed ID: 10833062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.